Cleared Traditional

K233354 - WVSM Pro (Series) (500-0030-XX)

K233354 is an FDA 510(k) clearance for WVSM Pro (Series) (500-0030-XX), manufactured by Athena Gtx, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 271-day FDA review.

K233354 · Athena Gtx, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
271d
Days
Class 2
Risk

K233354 is an FDA 510(k) clearance for the WVSM Pro (Series) (500-0030-XX). Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Athena Gtx, Inc. (Johnson, US). The FDA issued a Cleared decision on June 26, 2024 after a review of 271 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Athena Gtx, Inc. devices

FDA 510(k) Submission Details - K233354

510(k) Number K233354 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2023
Decision Date June 26, 2024
Days to Decision 271 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
146d slower than avg
Panel avg: 125d · This submission: 271d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 150
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K233354.
Sensinel Cardiopulmonary Management (CPM) System (ADCP1100)
K243216 · Analog Devices · Dec 2024
AMC Health CareConsole
K233446 · Amc Health · Sep 2024
Happy Ring Health Monitoring System
K240236 · Happy Health, Inc. · Sep 2024
NeoBeat, NeoBeat Mini
K232111 · Laerdal Medical AS · Jun 2024
Portrait VSM
K233810 · Ge Medical Systems Information Technologies, Inc. · Apr 2024
Talis EMR with Talis +ACG (Talis EMR with +ACG)
K233133 · Talis Clinical, LLC · Apr 2024